SCHOLAR ROCK HOLDING CORPORATION Class of Warrant or Right, Outstanding
SCHOLAR ROCK HOLDING CORPORATION (SRRK) had Class of Warrant or Right, Outstanding of 27.69 million shares as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2022-11-14
- 2022-09-30: Class of Warrant or Right, Outstanding 27.69M shares.
- 2022-06-30: Class of Warrant or Right, Outstanding 27.69M shares.
- 2022-03-31: Class of Warrant or Right, Outstanding 2.18M shares.
- 2021-09-30: Class of Warrant or Right, Outstanding 2.18M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2022-09-30 | 27.69M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 27.69M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 2.18M shares 10-Q · filed 2022-05-16 |
| 2021-09-30 | 2.18M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 2.18M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 2.18M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |